May 4th 1st quarter earnings report looming !

Discussion in 'Esperion' started by anonymous, Apr 18, 2021 at 11:15 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Can Esperion withstand another pitiful earnings report. Will the investors pull the plug on this dog? Is there an escape plan? Will Tim mention Covid at least 25 times? Will we hear uptick,traction ,momentum and runway?? Will there be one meaningful question asked that gets a straight answer? Will media session be another softball Oprah, Larry King, Ellen type queations?? How much rehearsal this time with media members?? Will Esperion do more than 12 million this quarter with this potential billion dollar blockbuster? Will CB make a guest appearance or will Sheledon be doing a live call in on his bike??
     

  2. anonymous

    anonymous Guest

    It will be like all of them so far. Awful and big talk about breakthrough coming at any moment. Amazing the money train hasn't been pulled on this disaster.
     
  3. anonymous

    anonymous Guest

    I keep hearing last last 5 weeks are flat. We no longer get the weeklies but if this is true that will be very hard to explain
     
  4. anonymous

    anonymous Guest

    Any of the other companies that report data aren't seeing any type of consistency in reporting of BA numbers. Obviously Ann Arbor is sandbagging the numbers to not show what we all know that there's no growth. The quarterly money burn rate will be interesting to see. 4th quarter was 103 million burned. What is Ann Arbor hiding from investors? This can't be legit. Every other company in LDL selling space pays no attention to BA. Its irrelevant and looked upon as another generic statin. This will be an ugly report.
     
  5. anonymous

    anonymous Guest

    It is curious. In the beginning, we got full reports of writers so we could see who was writing all over the country. Now our manager edits it so we can only see our own.
     
  6. anonymous

    anonymous Guest

    Lol

    You are giving away to play book !
     
  7. anonymous

    anonymous Guest

    So not to see how bad the rest of the country is doing. Stock is down as its Monday. The % of new writers is alarming per territory and region. Get out while you can as this will end soon. No company can burn money like this and expect investors to be pleased especially when they see no growth.
     
  8. anonymous

    anonymous Guest

    What is the strategy if the 1st Qtr. numbers disappoint and the cash burn continues at the high rate ?

    Will there be new messaging ?
    More layoffs ?
     
  9. anonymous

    anonymous Guest

    Numbers have been flat for 9 weeks. No growth. This call will say a great deal about the future of BA. You can only massage the numbers and put spin control out there so much. The revamping and cutting sales teams to show an increase in weekly numbers might of fooled some of the dopes on the last call but will will be difficult this time. Even if they show a minor amount of increase and quarterly numbers come in around 13 million this is still way shy of the billion dollar potential bragged about at launch. No company can burn the amount of money Esperion is doing with so little sales. Last quarter as 104 million burned. You would need to do 75 million in sales to show growth projections that make this a feasible success. So far we've seen none of this. There should be an escape plan in place for reps as this won't end up being a good ending.
     
  10. anonymous

    anonymous Guest

    Is that what you think in revenue? 13M? What if 22M is reported? Would that be acceptable Quarter over Quarter growth?
     
  11. anonymous

    anonymous Guest

    With the lipid market if your not doing 50 million a quarter than anything less is failure. 15-20 million is still pitiful in a multi- billion dollar market. Even with all the roadblocks that PCSK9 products had Repatha still did close to 300 million per year and Praluent around 220. This is with the most difficult prior auth process in the selling space. What's been accomplished at Esperion is not even in the same league. The powers to be at Esperion are all about looting as much money as they can from investors to keep the company afloat and the board leading the good life.
     
  12. anonymous

    anonymous Guest

    I understand but it seem like it’s heading that direction. It looks like cholesterol testing in general was indeed significantly down during the pandemic. This white paper from Journal of Cardiology was just released stating it was down 70% from March thru September in 2020 and 90% down from March to June. Looks like 50m+ per quarter will definitely be achieved this year if this growth continues and cholesterol testing is indeed now ramping up. Here’s the paper
    https://www.sciencedirect.com/science/article/pii/S2666667721000076
     
  13. anonymous

    anonymous Guest

    The previous post again is corporate lackey bullshit to make up another excuse for the 4th quarter. That's a newone, a white paper which holds up about much weight in clinical relevance as if it was white toilet paper. Let's know why this company continues to fumble, bumble and stumble. Stop making every kind of excuse you can think up Ann Arbor lackey. You've failed miserably with this 3rd rate drug. Now its testing was down . Give me a break. The PCSK9 market and generic statins completely kicked your ass again. Give up!! Say Uncle !! Your in a fucking headlock and your losing oxygen. Total delusional sociopath thing. Just do what you do best. STEAL MONEY FROM INVESTORS.
     
  14. anonymous

    anonymous Guest

    Buddy, relax. Everything will be okay.
     
  15. anonymous

    anonymous Guest

    There is a lot to look forward to, clearly the market will grow as people return back to the doctors and more tests are run. We are in the right place at the right time with a great product, and it’s up to us to move the needle as things open up I feel good about my team and I feel good about my territory, the positive momentum we are seeing is providing a positive feedback loop that is motivating us to do more.
     
  16. anonymous

    anonymous Guest

    What feedback are your hearing? It's a disaster ..you can feel good all you want about momentum and upticks. There's nothing positive going on . Its circling the drain corporate lackey. You continue to embarass yourself with your ridiculous posts. Your only showing how inept and how you thrive innately deceitful business atmosphere.
     
  17. anonymous

    anonymous Guest

    It seems like this poster has an axe to grind with Esperion; not sure what their issue is or if maybe just trying to stir the pot?
     
  18. anonymous

    anonymous Guest

    Buckle up for tomorrow dipshit. Your career dissipation light just went off like a blinking lighthouse.
     
  19. anonymous

    anonymous Guest

    Mr Feelings:

    When facts arrive, tomorrow, please spare us your attempt to convince your fickle, feeling, followers, that everything will be rosy.
     
  20. anonymous

    anonymous Guest

    You can count on major spin control today. A Biden press conference has nothing on this. Tim's calling should be politics. This will be daunting for this company to recover after such severe losses since launch.